To recover your password please fill in your email address
Please fill in below form to create an account with us
A multicentre randomised phase II trial comparing nab-paclitaxel to paclitaxel in patients with advanced urothelial cancer progressing on or after a platinum containing regimen.
|
Trial Summary: |
This is a CCTG led phase II, multicentre, open-label study to assess whether there is a difference in progression free survival between patients receiving paclitaxel and those receiving nab-paclitaxel. |
|
Supported By: |
STA; NHMRC CTC |
|
Eligibility: |
Patients with advanced urothelial cancer who have progressed on or after a platinum containing regimen. |
|
Registration ID: |
ACTRN12614001079639 |
|
Participation: |
International |
|
Australian Lead Group: |
ANZUP |
|
Status: |
Closed |
|
Activation Date: |
17/04/2015 |
|
Chairs: |
Dr Ben Tran |
|
Contact: |